Genesis Drug Discovery & Development (GD³)
William Solvibile has extensive experience in drug discovery and development, currently serving as a Business Development Manager at Genesis Drug Discovery & Development since August 2021. Prior to this role, William has held positions at Venenum BioDesign, LLC as a Research Associate since January 2015, and worked as a Senior Research Investigator at Rutgers University under Professor Richard Ebright from 2013 to January 2015, focusing on the design of antimicrobial targets. Their earlier experience includes positions as a Senior Associate Scientist in Medicinal Chemistry at Provid Pharmaceuticals, a Research Scientist II at Pfizer, and a Research Scientist I and II at Wyeth Research. William holds a Master of Arts in Chemistry from Temple University and a Bachelor of Science in Chemistry from Albright College.
This person is not in the org chart
This person is not in any teams
Genesis Drug Discovery & Development (GD³)
Genesis Drug Discovery and Development (GD3), a member of the Genesis Biotechnology Group is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, and microbiome.